+35.4%
CVS vs SSNC
-3.0%
+38.4%
-16.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SSNC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.5% | -1.2% | +0.7% | -0.4% |
| 7D | +4.0% | +0.6% | +3.3% | +3.9% |
| 30D | -2.4% | +6.0% | -8.4% | -2.5% |
| 3M | +2.7% | +21.0% | -18.3% | +2.4% |
| 6M | +21.9% | +12.1% | +9.8% | +21.9% |
| YTD | +24.7% | -3.2% | +28.0% | +24.9% |
| 1Y | +35.4% | -4.4% | +39.8% | +35.8% |
| All | +35.4% | -3.0% | +38.4% | +35.8% |
Cumulative growth
Daily Returns
Daily percentage return beside SSNC.
Daily Out/Under-Performance
Portfolio return minus SSNC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SSNC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SSNC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling